Latest news with #AmitVarma
&w=3840&q=100)
Business Standard
17-06-2025
- Business
- Business Standard
Quadria Group announces HealthQuad Fund III with $300 million corpus
Private equity firm Quadria Group on Tuesday announced the launch of HealthQuad Fund III, with a target corpus of $200 million and a $100 million in greenshoe option. HealthQuad Fund III succeeds Funds I and II, which have supported over 18 healthcare companies, including Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences. Quadria Group is aiming to raise $300 million (about Rs 2,550 crore) for its HealthQuad Fund III. Quadria Group has retained a large part of the existing investment and investment committee team members, who will continue to be involved in the existing portfolio investments, a company statement said. It will also add more people to its investing, operating and clinical team. "India presents one of the world's most compelling healthcare investment opportunities, driven by growing demand, digital acceleration, and underserved segments across primary, diagnostic, and chronic care. "With the full ownership of Fund III and expanded leadership, we are better positioned than ever to deliver cross-regional value for our portfolio companies, across South Asia, Southeast Asia, and the GCC, creating an unparalleled platform for health innovation," Amit Varma, co-founder and Investment Committee member, HealthQuad, said. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Time of India
17-06-2025
- Business
- Time of India
Quadria Group launches third HealthQuad fund with a corpus of $300 million
MUMBAI: Quadria Group, a healthcare-focused private equity platform on Tuesday announced the launch of HealthQuad Fund III, with a proposed raise of up to $300 million. The fund seeks to back healthcare ventures that have significantly expanded access, affordability, and quality of care across India. Funds I and II backed over 18 companies including Medikabazaar, THB, Wysa, Ekincare, Redcliffe Labs, GoApptiv, and Strand Life Sciences. Dr. Amit Varma, Co-founder and Investment Committee member, HealthQuad, said, 'India presents one of the world's most compelling healthcare investment opportunities—driven by growing demand, digital acceleration, and underserved segments across primary, diagnostic, and chronic care. With the full ownership of Fund III and expanded leadership, we are better positioned than ever to deliver cross-regional value for our portfolio companies, across South Asia, Southeast Asia, and the GCC, creating an unparalleled platform for health innovation. ' Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
17-06-2025
- Business
- Time of India
Quadria Group launches HealthQuad Fund III to improve healthcare accessibility
New Delhi / Mumbai: Healthcare-focused Private equity firm Quadria Group has announced the launch of HealthQuad Fund III . The new fund has a target corpus of $200 million, with an additional $100 million greenshoe option. HealthQuad Fund III follows two earlier funds that supported early-stage, tech-enabled healthcare ventures in India. The stated aim of the fund is to continue investing in models that improve access, affordability, and quality of care. HealthQuad was launched in 2016 as a separate investment vehicle within Quadria to focus on early-growth healthcare innovations. As part of the latest development, Quadria Group states it will take full ownership of the HealthQuad platform following its separation from KOIS. Dr. Amit Varma, Abrar Mir, and Sunil Thakur will lead the platform, and most existing investment and investment committee team members will remain involved with the portfolio. Quadria also indicates plans to expand the team with new hires from investment, operations, and clinical backgrounds, to be announced shortly.
&w=3840&q=100)
Business Standard
27-05-2025
- Business
- Business Standard
Quadria closes $1.07 bn healthcare fund, seeks growth in India and S Asia
Quadria Capital has closed its Fund III at $1.07 billion after exceeding the target to raise $800 million, said the healthcare-focused private equity (PE) firm on Tuesday. The amount raised includes $954 million in primary commitments and $114 million as co-investment capital. A further $300 million is expected to be raised in co-investments later and the total capital available could reach up to $1.3 billion, said the Singapore-based firm in a statement. The amount raised is almost 60 per cent more from the $600 million the company's second plan got in 2020, making III the largest dedicated healthcare PE fund for South and Southeast Asia. 'Asia's healthcare sector is at a pivotal moment, and it will remain in the limelight in 2025, especially with investment interest in India in areas like single speciality hospitals, diagnostic chains, medical devices, and pharmaceutical manufacturing,' said Amit Varma, cofounder and managing partner at Quadria Capital. The sector will grow because of higher healthcare consumption, 'cost-efficiency initiatives and technology integration', he said. Fund III drew participation from existing investors, who boosted their commitments by an average of 80 per cent, as well as global institutions across North America, Europe, the Middle East, and Asia. New backers included sovereign wealth funds, insurance firms, and family offices, particularly from west Asia and India. Fund III is already nearly 40 per cent deployed, with investments in Aragen Life Sciences, NephroPlus, and Maxivision. Two additional transactions in Southeast Asia are expected to close soon, the company said. Founded in 2012, Quadria manages more than $4 billion in assets across 27 companies. The firm said it plans to build a portfolio of about 10 market-leading healthcare businesses with Fund III, through majority and minority stakes, and co-investments.
Reuters
27-05-2025
- Business
- Reuters
Quadria Capital secures $1.07 billion for third Asia healthcare fund
SINGAPORE, May 27 (Reuters) - Asian healthcare-focused private equity firm Quadria Capital said on Tuesday it has secured total commitments of $1.07 billion for its third fund, surpassing an original target of $800 million. Reuters reported in September 2023 that Quadria was looking to raise up to $1 billion for its third and biggest fund to tap into the fast-growing sector in South and Southeast Asia. "Asia's healthcare sector is at a pivotal moment, and it will remain in the limelight in 2025, especially with investment interest in India," Amit Varma, co-founder and managing partner of Quadria, said in a statement. Quadria said the fundraise is around 60% larger than its previous $600 million fund raised in 2020, making it the largest healthcare private equity fund in South and Southeast Asia. It said the oversubscribed fundraise comprises over $954 million in primary commitments and $114 million in committed co-investment capital, with an additional $300 million co-investment anticipated over the course of the investment phase. It added that its largest existing backers include North American and European sovereign wealth funds, asset managers and strategic corporates. The company said it also secured new commitments from global institutional investors including strong backing across the Gulf Cooperation Council and interest from India as well as commitments from impact investors. Quadria said the fund will build a diversified portfolio of around 10 market-leading companies, taking both significant minority and majority stakes. It added that already nearly 40% of the fund was deployed, with investments made in Aragen Life Sciences, dialysis chain NephroPlus and eye care chain Maxivision. Quadria said two new investments in Southeast Asia are expected soon.
